The control of blood glucose in the critical diabetic patient: a neuro-fuzzy method
Conventional algorithms for regulating insulin infusion rates in those critical diabetic patients submitted to parenteral glucose and insulin infusions do not allow to approach near normal blood glucose (BG) levels since traditional control systems are not fully effective in complex nonlinear system...
        Saved in:
      
    
          | Published in | Journal of diabetes and its complications Vol. 15; no. 2; pp. 80 - 87 | 
|---|---|
| Main Authors | , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        New York, NY
          Elsevier Inc
    
        01.03.2001
     Elsevier Science  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1056-8727 1873-460X  | 
| DOI | 10.1016/S1056-8727(00)00137-9 | 
Cover
| Summary: | Conventional algorithms for regulating insulin infusion rates in those critical diabetic patients submitted to parenteral glucose and insulin infusions do not allow to approach near normal blood glucose (BG) levels since traditional control systems are not fully effective in complex nonlinear systems as BG control is. Thus, we applied fuzzy logic principles and neural network techniques to modify intravenous insulin administration rates during glucose infusion. Forty critically ill, fasted diabetic subjects submitted to glucose and potassium infusion entered the study. They were randomly assigned to two treatment regimes: in group A, insulin infusion rates were adjusted, every 4 h at any step between −1.5 and +1.5 U/h, according to a neuro-fuzzy nomogram; in control group B, insulin infusion rates were modified according to a conventional algorithm. In group A, BG was lowered below 10 mmol/l faster than in group B (8.2±0.7 vs. 13±1.8 h,
P<.02). Mean BG was 7.8±0.2 in group A and 10.6±0.3 mmol/l in group B (
P<.00001). BG values below 4.4 mmol/l were: A=5.8% and B=10.2%. BG values lower than 2.5 mmol/l had never been observed. In conclusion, the neuro-fuzzy control system is effective in improving the BG control in critical diabetic patients without increasing either the number of BG determinations or the risk of hypoglycemia. | 
|---|---|
| Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3  | 
| ISSN: | 1056-8727 1873-460X  | 
| DOI: | 10.1016/S1056-8727(00)00137-9 |